Utility of the acute phase inflammatory risk index as a predictor of severity in preeclampsia

Descripción del Articulo

Objective: determine the usefulness of the acute phase inflammatory risk index as a predictor of severity in preeclampsia. Material and method: an analytical observational study of diagnostic tests was carried out, in which 152 pregnant women in the third trimester of pregnancy attended by the Gynec...

Descripción completa

Detalles Bibliográficos
Autores: Rios-Mino, Diana L., Rodríguez-Barboza, Héctor U.
Formato: artículo
Fecha de Publicación:2023
Institución:Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo
Repositorio:Revista del Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo
Lenguaje:español
OAI Identifier:oai:cmhnaaa_ojs_cmhnaaa.cmhnaaa.org.pe:article/1915
Enlace del recurso:https://cmhnaaa.org.pe/ojs/index.php/rcmhnaaa/article/view/1915
Nivel de acceso:acceso abierto
Materia:Pre-Eclampsia
Índice de riesgo
Índice de severidad de la enfermedad
Pre – eclampsia
Risk index
Severity of Illness Index
id REVCMH_8d9215856d3e05b2dfa3fdaa4c77968f
oai_identifier_str oai:cmhnaaa_ojs_cmhnaaa.cmhnaaa.org.pe:article/1915
network_acronym_str REVCMH
network_name_str Revista del Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo
repository_id_str
dc.title.none.fl_str_mv Utility of the acute phase inflammatory risk index as a predictor of severity in preeclampsia
Utilidad del Indice de riesgo inflamatorio de fase aguda como predictor de severidad en preeclampsia
title Utility of the acute phase inflammatory risk index as a predictor of severity in preeclampsia
spellingShingle Utility of the acute phase inflammatory risk index as a predictor of severity in preeclampsia
Rios-Mino, Diana L.
Pre-Eclampsia
Índice de riesgo
Índice de severidad de la enfermedad
Pre – eclampsia
Risk index
Severity of Illness Index
title_short Utility of the acute phase inflammatory risk index as a predictor of severity in preeclampsia
title_full Utility of the acute phase inflammatory risk index as a predictor of severity in preeclampsia
title_fullStr Utility of the acute phase inflammatory risk index as a predictor of severity in preeclampsia
title_full_unstemmed Utility of the acute phase inflammatory risk index as a predictor of severity in preeclampsia
title_sort Utility of the acute phase inflammatory risk index as a predictor of severity in preeclampsia
dc.creator.none.fl_str_mv Rios-Mino, Diana L.
Rodríguez-Barboza, Héctor U.
author Rios-Mino, Diana L.
author_facet Rios-Mino, Diana L.
Rodríguez-Barboza, Héctor U.
author_role author
author2 Rodríguez-Barboza, Héctor U.
author2_role author
dc.subject.none.fl_str_mv Pre-Eclampsia
Índice de riesgo
Índice de severidad de la enfermedad
Pre – eclampsia
Risk index
Severity of Illness Index
topic Pre-Eclampsia
Índice de riesgo
Índice de severidad de la enfermedad
Pre – eclampsia
Risk index
Severity of Illness Index
description Objective: determine the usefulness of the acute phase inflammatory risk index as a predictor of severity in preeclampsia. Material and method: an analytical observational study of diagnostic tests was carried out, in which 152 pregnant women in the third trimester of pregnancy attended by the Gynecology – Obstetrics service of the Belén Hospital of Trujillo were included, divided into two groups: 76 pregnant women with a diagnosis of preeclampsia with and without severity criteria. In these groups, the following parameters were evaluated: neutrophil/lymphocyte ratio (INL), platelet/lymphocyte ratio (PLI), hemoconcentration, hematocrit/albumin ratio (HAI), mean platelet volume (MPV), erythrocyte distribution width (RDW)  and the acute phase inflammatory risk index. Results: in the laboratory characteristics, the neutrophil lymphocyte index (NLR), platelet lymphocyte index (LPI), hemoconcentration, mean platelet volume (MPV) and erythrocyte distribution width (RDW), by themselves, did not have statistical significance. However, the albumin hematocrit index >12 alone did obtain statistical significance (p=0.001). Likewise, the inflammatory risk index as a predictor of severity was associated with severity in preeclampsia. Through the ROC curves, it was found that the best cut-off point was 2.5, sensitivity 68.4%, specificity 50.0%, positive predictive value 57.8% and negative predictive value 61.3%. Conclusion:  the Acute Phase Inflammatory Risk Index > 2.5 should be considered a useful factor for predicting severity in preeclampsia.
publishDate 2023
dc.date.none.fl_str_mv 2023-10-27
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv https://cmhnaaa.org.pe/ojs/index.php/rcmhnaaa/article/view/1915
10.35434/rcmhnaaa.2023.163.1915
url https://cmhnaaa.org.pe/ojs/index.php/rcmhnaaa/article/view/1915
identifier_str_mv 10.35434/rcmhnaaa.2023.163.1915
dc.language.none.fl_str_mv spa
language spa
dc.relation.none.fl_str_mv https://cmhnaaa.org.pe/ojs/index.php/rcmhnaaa/article/view/1915/840
dc.rights.none.fl_str_mv Derechos de autor 2023 Diana L. Rios-Mino, Héctor U. Rodríguez-Barboza
https://creativecommons.org/licenses/by/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Derechos de autor 2023 Diana L. Rios-Mino, Héctor U. Rodríguez-Barboza
https://creativecommons.org/licenses/by/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Cuerpo Médico del Hospital Nacional Almanzor Aguinaga Asenjo
publisher.none.fl_str_mv Cuerpo Médico del Hospital Nacional Almanzor Aguinaga Asenjo
dc.source.none.fl_str_mv Revista del Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo; Vol. 16 No. 3 (2023): Rev. Cuerpo Med. HNAAA, July - September; e1915
Revista del Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo; Vol. 16 Núm. 3 (2023): Rev. Cuerpo Med. HNAAA, Julio - Setiembre; e1915
2227-4731
2225-5109
10.35434/rcmhnaaa.2023.163
reponame:Revista del Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo
instname:Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo
instacron:HNAAA
instname_str Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo
instacron_str HNAAA
institution HNAAA
reponame_str Revista del Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo
collection Revista del Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1842629792887734272
spelling Utility of the acute phase inflammatory risk index as a predictor of severity in preeclampsiaUtilidad del Indice de riesgo inflamatorio de fase aguda como predictor de severidad en preeclampsiaRios-Mino, Diana L.Rodríguez-Barboza, Héctor U.Pre-EclampsiaÍndice de riesgoÍndice de severidad de la enfermedadPre – eclampsiaRisk indexSeverity of Illness IndexObjective: determine the usefulness of the acute phase inflammatory risk index as a predictor of severity in preeclampsia. Material and method: an analytical observational study of diagnostic tests was carried out, in which 152 pregnant women in the third trimester of pregnancy attended by the Gynecology – Obstetrics service of the Belén Hospital of Trujillo were included, divided into two groups: 76 pregnant women with a diagnosis of preeclampsia with and without severity criteria. In these groups, the following parameters were evaluated: neutrophil/lymphocyte ratio (INL), platelet/lymphocyte ratio (PLI), hemoconcentration, hematocrit/albumin ratio (HAI), mean platelet volume (MPV), erythrocyte distribution width (RDW)  and the acute phase inflammatory risk index. Results: in the laboratory characteristics, the neutrophil lymphocyte index (NLR), platelet lymphocyte index (LPI), hemoconcentration, mean platelet volume (MPV) and erythrocyte distribution width (RDW), by themselves, did not have statistical significance. However, the albumin hematocrit index >12 alone did obtain statistical significance (p=0.001). Likewise, the inflammatory risk index as a predictor of severity was associated with severity in preeclampsia. Through the ROC curves, it was found that the best cut-off point was 2.5, sensitivity 68.4%, specificity 50.0%, positive predictive value 57.8% and negative predictive value 61.3%. Conclusion:  the Acute Phase Inflammatory Risk Index > 2.5 should be considered a useful factor for predicting severity in preeclampsia.Objetivo: determinar la utilidad del índice de riesgo inflamatorio de fase aguda como factor predictor de severidad en preeclampsia. Material y método: se realizó un estudio observacional analítico, de pruebas diagnósticas, en el que se incluyeron a 152 gestantes en el tercer trimestre de gestación atendidas por el servicio de Gineco – Obstetricia del Hospital Belén de Trujillo, divididas en dos grupos: 76 gestantes con diagnóstico de preeclampsia con criterios y sin criterios de severidad. En dichos grupos se evaluaron los siguientes parámetros: índice neutrófilos/linfocitos (INL), índice plaquetas/linfocitos (IPL), hemoconcentración, índice hematocrito/albúmina (IHA), el volumen plaquetario medio (VPM), la amplitud de distribución eritrocitaria (ADE) y el índice de riesgo inflamatorio de fase aguda. Resultados: en las características laboratoriales el índice neutrófilo linfocito (INL), índice plaquetas linfocito (IPL), hemoconcentración, volumen plaquetario medio (VPM) y amplitud de distribución eritrocitaria (ADE), por sí solos, no tuvieron significancia estadística. Sin embargo, el índice hematocrito albúmina >12 por sí solo, si obtuvo significancia estadística (p=0.001).  Así mismo el índice de riesgo inflamatorio como predictor de severidad, sí se asoció a severidad en preeclampsia. A través de las curvas ROC, se encontró que el mejor punto de corte fue de 2.5, sensibilidad 68.4%, especificidad 50.0%, valor predictivo positivo 57.8% y valor predictivo negativo 61.3%. Conclusión:  el índice de Riesgo Inflamatorio de Fase Aguda > de 2.5   debería ser considerado como un factor útil para la predicción de severidad en preeclampsia.Cuerpo Médico del Hospital Nacional Almanzor Aguinaga Asenjo2023-10-27info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://cmhnaaa.org.pe/ojs/index.php/rcmhnaaa/article/view/191510.35434/rcmhnaaa.2023.163.1915Revista del Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo; Vol. 16 No. 3 (2023): Rev. Cuerpo Med. HNAAA, July - September; e1915Revista del Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo; Vol. 16 Núm. 3 (2023): Rev. Cuerpo Med. HNAAA, Julio - Setiembre; e19152227-47312225-510910.35434/rcmhnaaa.2023.163reponame:Revista del Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjoinstname:Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjoinstacron:HNAAAspahttps://cmhnaaa.org.pe/ojs/index.php/rcmhnaaa/article/view/1915/840Derechos de autor 2023 Diana L. Rios-Mino, Héctor U. Rodríguez-Barbozahttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessoai:cmhnaaa_ojs_cmhnaaa.cmhnaaa.org.pe:article/19152025-03-11T15:55:20Z
score 12.649037
Nota importante:
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).